UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2008
OR
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2008

OR
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number: 333-64840

CELSIA TECHNOLOGIES INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Nevada
 
91-2015441
(State or Other Jurisdiction of (IRS Employer
Incorporation or Organization)Identification No.)
   
1395 Brickell Avenue, Suite 800, Miami
Florida
 
33131
(Address of Principal Executive Offices) (Zip Code)
 
(305) 529-6290
(Registrant’s Telephone Number, Including Area Code)
 
None
(Former Name, Former Address and Former Fiscal year, if Changed Since Last Report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨
Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
¨ No x
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class Outstanding at May 13,November 10, 2008
Common Stock, $.01 par value per share 85,565,71386,561,449 shares



TABLE OF CONTENTS

  
Page
   
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets as of September 30, 2008 (unaudited) and December 31, 2007 1
   
Item 1.Consolidated Statements of Operations (unaudited) for the three month and nine month periods ended September 30, 2008 and 20072
Consolidated Statements of Cash Flows (unaudited) for the nine month periods ended September 30, 2008 and 20073
Notes to Condensed Consolidated Financial Statements14-10
   
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations1311
Item 3. Quantitative and Qualitative Disclosures about Market Risk15
Item 4T. Controls and Procedures15
   
Item 3.Quantitative and Qualitative Disclosures about Market Risk16
PART II. OTHER INFORMATION  
Item 4.1. Legal ProceedingsControls and Procedures16
Item 2. Exhibits17
   
PART II.Signatures 18
Item 6.Exhibits18
 
-i-

FORWARD-LOOKING STATEMENTS

Some of the statements under ‘‘Business,’’ ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations,’’ “Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our strategy, future operations, future financial position, future revenues, projected costs, prospects, and the plans and objectives of management and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘could,’’ ‘‘would,’’ ‘‘expects,’’ ‘‘plans,’’ ‘‘intends,’’ ‘‘anticipates,’’ ‘‘believes,’’ ‘‘estimates,’’ ‘‘predicts,’’ ‘‘potential’’ or ‘‘continue’’ or the negative of such terms and other comparable terminology.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we do not know whether we can achieve positive future results, levels of activity, performance, or goals. Actual events or results may differ materially. We caution readers not to place undue reliance on any forward-looking statements, which speak only as of the date made, and advise readers that forward-looking statements involve various risks and uncertainties. We undertake no obligation to update any of the forward-looking statements after the date of this Quarterly Report to conform to those statements to reflect the occurrence of unanticipated events, except as required by applicable law.

PART II.
FINANCIAL INFORMATION

Item 1.
Financial Statements.Statements.

Celsia Technologies, Inc. and Subsidiaries
Consolidated Balance Sheet
(US Dollars)

 March 31, 2008
 
December 31, 2007  September 30, 2008 December 31, 2007 
 (unaudited)    (unaudited)   
Assets
            
Current Assets            
Cash and cash equivalents $2,387,729 $3,046,624  $1,008,467 $3,046,624 
Receivable  407,324  298,799   318,435  298,799 
Inventory  92,769  74,465   68,453  74,465 
Prepaid expenses  63,893  45,661   115,115  45,661 
Other  19,075  31,785   4,094  31,785 
Total current assets  2,970,790  3,497,334   1,514,564  3,497,334 
              
Guarantee deposits  25,132  26,157   20,468  26,157 
Advance payments  145,979  154,287   -  154,287 
              
Furniture and equipment, net (note 1)  671,420  639,947   591,057  639,947 
Deferred Charges (note 1)  1,544,034  1,721,630 
Deferred Financing Costs (note 1)  1,188,842  1,721,630 
Royalty Advance (note 3)  -  -   -  - 
Intangible Assets, net (note 3)  89,934  85,049   -  85,049 
              
Total assets $5,447,289 $6,124,404  $3,314,931 $6,124,404 
              
Liabilities and Stockholders’ Equity (Deficit)
       
Liabilities and Stockholders' Equity (Deficit)
       
Current liabilities              
Accounts payable $531,244 $282,055  $575,711 $282,055 
Bond Payable (note 4)  303,475  322,582   248,707  322,582 
Accrued expenses              
Payroll and Related  666,917  652,917   684,917  652,917 
Other  464,173  576,917   715,062  576,917 
Accrual for Employee Retirement Benefits (note 3)  87,556  - 
Other  24,667  26,545   34,325  26,545 
Total current liabilities  1,990,476  1,861,016   2,346,278  1,861,016 
              
Convertible Debenture, net of $3,668,736 as of March 31, 2008 and $4,092,051 as of December 31, 2007 unamortized discount (note 6)  5,229,047  4,400,796 
Accrual for Employee Retirement Benefits (note 3)  94,030  86,683   -  86,683 
Convertible Debenture, net of $2,832,104 as of September 30, 2008 and $4,092,051 as of December 31, 2007 unamortized discount (note 6)  6,065,679  4,400,796 
              
Total liabilities  7,313,553  6,348,495   8,411,957  6,348,495 
              
Stockholders’ Equity (Deficit) (note 6 & 7)       
Preferred Stock, Series A; $.001 par value; 30,000,000 shares authorized; 22,032,963 as of March 31, 2008 and 22,320,598 as of December 31, 2007 issued and outstanding  22,033  22,321 
Preferred Stock, Series B; $.001 par value; 7,000,000 shares authorized; 3,063,402 as of March 31, 2008 and December 31, 2007 issued and outstanding  3,063  3,063 
Common stock; $.001 par value; 500,000,000 shares authorized; 85,565,713 as of March 31, 2008 and 85,273,680 as of December 31, 2007 issued and outstanding  85,566  85,273 
Stockholders' Equity (Deficit) (note 6 & 7)       
Preferred Stock, Series A; $.001 par value; 30,000,000 shares authorized; 21,306,261 as of September 30, 2008 and 22,320,598 as of December 31, 2007 issued and outstanding  21,306  22,321 
Preferred Stock, Series B; $.001 par value; 7,000,000 shares authorized; 3,063,402 as of September 30, 2008 and December 31, 2007 issued and outstanding  3,063  3,063 
Common stock; $.001 par value; 750,000,000 shares authorized; 86,561,449 as of September 30, 2008 and 85,273,680 as of December 31, 2007 issued and outstanding  86,562  85,273 
Common stock subscribed  6,158  6,158   6,158  6,158 
Additional paid-in-capital  40,085,518  40,032,066   40,204,229  40,032,066 
Other comprehensive loss  (96,997) (80,478)  (159,673) (80,478)
Accumulated (deficit)  (41,971,605) (40,292,494)  (45,258,671) (40,292,494)
Total stockholders’ equity (deficit)  (1,866,264) (224,091)
Total stockholders' equity (deficit)  (5,097,026) (224,091)
              
Total liabilities and stockholders’ equity (deficit) $5,447,289 $6,124,404 
Total liabilities and stockholders' equity (deficit) $3,314,931 $6,124,404 

See accompanying notes to consolidated financial statements

1


Celsia Technologies, Inc. and Subsidiaries
Consolidated Statements of Operations
(US Dollars)

  
Three Months Ended
March 31,
 
  2008 2007 
      
Revenue $305,688 $99,323 
        
Costs and expenses       
Cost of Sales  294,725  166,538 
Selling and Administrative expenses  740,555  956,962 
Depreciation  16,969  43,474 
Amortization of deferred financing cost (note 1)  193,300  5,053 
Miscellaneous (income) expense  11,712  663 
Total costs and expenses  1,257,261  1,172,690 
        
Operating (loss)  (951,573) (1,073,367)
        
Other income (expenses)       
        
Financing Expense (note 6)  (177,956) - 
Interest and other income  83,539  (27,300)
Interest expense (notes 5 and 6)  (633,121) (16,056)
        
Total other income (expenses)  (727,538) (43,356)
        
Net (loss) $(1,679,111)$(1,116,723)
        
Dividend on Series A Preferred Stock (note 7) $(97,942)$(400,322)
        
Net Loss Attributable to Common Shareholders $(1,777,053)$(1,517,045)
        
Net Loss per Share:       
Basic and Diluted $(0.02)$(0.04)
        
Weighted Average Shares Outstanding  85,376,373  36,382,907 

  Three Months Ended 
 
Nine Months Ended 
 
 
 
September 30, 
 
September 30,
 
 
 
2008
 
2007
 
2008
 
2007 
          
Revenue $228,157 $208,266 $948,203 $506,921 
              
Costs and expenses             
Cost of Sales  255,196  329,089  997,637  877,027 
Selling and Administrative expenses  815,008  1,057,060  2,235,824  2,599,364 
Depreciation  21,802  44,406  58,693  133,637 
Amortization of deferred financing cost (note 1)  177,596  147,761  548,492  231,925 
Miscellaneous (income) expense  (4,817) (3,054) 19,502  1,898 
Total costs and expenses  1,264,785  1,575,262  3,860,148  3,843,851 
              
Operating (loss)  (1,036,628) (1,366,996) (2,911,945) (3,336,930)
              
Other income (expenses)             
              
Financing Expense (note 6)  -  (3,430,591) (177,956) (9,491,155)
Interest and other income  (43,885) 77,567  57,189  116,912 
Loss from Impairment of Intangible Asset  (129,432)    (129,432)   
Interest expense (notes 5 and 6)  (603,691) (626,113) (1,804,035) (812,076)
              
Total other income (expenses)  (777,008) (3,979,137) (2,054,234) (10,186,319)
              
Net (loss) $(1,813,636)$(5,346,133)$(4,966,179)$(13,523,249)
              
Dividend on Series A Preferred Stock (note 7) $(97,742)$(101,296)$(292,363)$(142,440)
Deemed Dividend on Series A & B Preferred Stock          $(652,318)
              
Net Loss Attributable to Common Shareholders $(1,911,378)$(5,447,429)$(5,258,542)$(14,318,007)
              
Net Loss per Share:             
Basic and Diluted $(0.02)$(0.07)$(0.06)$(0.25)
              
Weighted Average Shares Outstanding  86,293,860  83,258,145  85,726,430  58,412,810 

See accompanying notes to consolidated financial statements

2


Celsia Technologies, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(US Dollars)

 March 31,  September 30, 
 2008 2007  2008 2007 
Cash flows from operating activities:            
Net (loss) $(1,679,111)$(1,116,723) $(4,966,179)$(13,523,249)
Adjustments to reconcile net (loss) to net cash (used) by operating activities:              
Depreciation  16,969  43,474   58,693  133,637 
Amortization of Deferred Charges  193,300  5,053 
Amortization of Deferred Financing Costs  548,492  231,925 
Issuance of Common Stock for Debenture Principal and Interest Conversion  12,660    
Interest on Convertible Debt  -    
Issuance of warrants for service  -  75,229 
Issuance of warrants as settlement     32,700 
Beneficial Conversion Feature     3,430,591 
Amortization of Debt Discount  423,316  -   1,259,947  574,736 
Accrete Interest on Convertible Debenture  404,936  - 
Financing Expense  404,936  -   -  6,060,564 
Stock Based Compensation  53,456  93,441   163,064  150,291 
Changes to certain other accounts:              
Receivable  (108,525) (53,151)  (19,636) (183,161)
Inventory  (18,304) 3,632   6,012  238 
Advance payments  8,308  10,128   154,287  (43,380)
Prepaid expenses  (18,232) 17,146   (69,454) (16,655)
Accounts payable  249,189  36,422   293,656  (48,038)
Accrued expenses  (98,744) 79,822   170,145  (208,510)
Accrual for Employee Retirement Benefits  7,347  (30,097)  873  (23,433)
Other  (45,383) 52,756   (51,539) (28,607)
Net cash (used) by operating activities  (611,478) (858,097)  (2,034,043) (3,385,122)
              
Cash flows from investing activities:              
Deposits  1,025  1,542 
Guarantee Deposits  5,689  (13,294)
Purchase of furniture and equipment  (48,442) (22,865)  (9,803) (64,119)
Net cash (used) by investing activities  (47,417) (21,323)  (4,114) (77,413)
              
Cash flows from financing activities:              
Deferred Finance Charge  -  (192,026)  -  (1,139,607)
Long-term borrowings      1,000,000 
Net cash (used) provided by financing activities  -  807,974 
Proceeds from Issuance of Convertible Debt  -  8,350,000 
Net cash provided by financing activities  -  7,210,393 
              
Net (decrease) increase in cash and cash equivalents  (658,895) (71,446)  (2,038,157) 3,747,858 
              
Cash and cash equivalents - beginning of period $3,046,624 $295,400  $3,046,624 $295,400 
              
Cash and cash equivalents - end of period $2,387,729 $223,954  $1,008,467 $4,043,258 
              
Supplemental cash flow disclosure              
Noncash financing activity              
              
During 2008 and 2007 the Company recorded stock compensation arrangements for certain employees and directors $53,456 $93,441  $163,064 $150,291 
              
During 2008 Preferred Shares were converted into Common Shares $288 $-  $1,014 $- 
       
During 2008, the Company recorded a premium given to the Debenture Holders as a Financing Expense $177,956 $- 
       
During 2007, the Company recorded a premium on the conversion of issued notes payable to convertible debenture as a deferred finance charge $- $115,000 
       
During 2007, the Company issued warrants to placement agents for convertible debenture as a deferred finance charge $- $876,544 

See accompanying notes to consolidated financial statements

3


Celsia Technologies, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
March 31,September 30, 2008

Note 1 - Summary of significant accounting policies

Organization

Celsia Technologies, Inc. (the "Company" or "Celsia"), a US Corporation incorporated in the State of Nevada, is formerly known as iCurie, Inc. Celsia’sCelsia's operations consist of research, development, and commercialization of next-generation cooling solutions. The Company was founded in 2000 to address the emerging heat problem that now threatens the development of higher-performing microelectronic products. Celsia is taking thisits innovative thermal management technology from the laboratory to high volume manufacturing, and operating as both a licensor of the technology and a vertically integrated provider of customized applications.

The Company’sCompany's corporate headquarters is located in Miami, Florida, USA with subsidiaries in London, United Kingdom, Seoul, South Korea, and Taipei, Taiwan. During 2007, the Company relocated its Design and Manufacturing operations from Seoul, Korea to Taipei, Taiwan. OurCelsia's operations in Seoul, Korea remainremained as a sales and administrative office for the region. OurThe Company's patented NanoSpreader™ is a completely new alternative to conventional cooling devices. By utilizing a nano scale environment, the laws of physics are manipulated enabling our cooling technology to be thinner, lighter and deliver significantly higher thermal conductivity (heat transfer capacity) versus conventional options such as Heat Pipes. And, we can supply our plate-shaped heat spreaders in virtually any shape that a design engineer requires. As a result, customers are able to achieve improved product performance without trading off size, weight or cost considerations.

Celsia Technologies, Inc.’sThe Company is currently in the process of shutting down the offices in Seoul, Korea and relocating any remaining functions to Taiwan. It is anticipated that this process will be complete by the end of 2008.

Celsia's subsidiaries consist of (i) Celsia Technologies UK Limited ("UK Subsidiary"), a United Kingdom Company formerly known as iCurie Lab Holdings Limited, (ii) Celsia Technologies Korea, Inc. ("Korea Subsidiary"), a Korean Company formerly known as iCurie Lab, Inc, and (iii) Celsia Technologies Taiwan, Inc. ("Taiwan Subsidiary"). In consolidation, all significant intercompany balances and transactions have been eliminated.

Financial reporting

The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America, which require management to make estimates and assumptions that affect the reported amounts in the financial statements. Although these statements are based on management’smanagement's best knowledge of current events and actions that the Company may undertake in the future, actual results could differ from those estimates.

Significant estimates required to be made by management include the valuation of equity securities issued, registration rights, intangible assets, and accoutingaccounting for convertible debentures.

Going Concern

The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company and its Subsidiariessubsidiaries have recently commenced limited revenue producing operations and have sustained accumulated losses of approximately $42.0$45.3 and $40.3 million as of March 31,September 30, 2008 and December 31, 2007, respectively. The Company and its Subsidiaries have funded operations through equity and debt financing since inception. All these factors raise substantial doubt over the Company’sCompany's ability to continue as a going concern.

Cash and Cash Equivalents

Cash and cash equivalents include all cash balances and highly liquid investments, including time deposits, which are readily convertible into known amounts of cash and have an original maturity dates of three months or less. The Company and its Subsidiary’sSubsidiary's cash and cash equivalents are maintained in banks and financial institutions in the United States, United Kingdom, South Korea, and Taiwan, and they have not experienced any losses on their cash balances.

Inventory

Inventory consists of finished goods ready to be sold to customers. Inventories are carried at the lower of cost or market value.

Investment

The UK Subsidiary owns 527,000 shares of an entity formerly affiliated through common management. These shares have been fully reserved and carry a book value of $0 as of March 31,September 30, 2008 and December 31, 2007.

4

Revenue recognition

The Company’sCompany's policy is to record revenue as earned when the following attributes are met.met:

-Persuasive evidence of a sale arrangement exists.
-Persuasive evidence of a sale arrangement exists;
-Delivery has occurred to the customers.
-Delivery has occurred to the customers;
-The sales price to the customer is fixed or determinable.
-The sales price to the customer is fixed or determinable; and
-Collection is reasonably assured.
-Collection is reasonably assured.

The Company recognized revenues of $305,688$948,203 and $99,323$506,921 for the threenine months ended March 31,September 30, 2008 and 2007, respectively, from customer orders for test samples and commercial deliveries.

4



Deferred financing costs

In connection with obtaining debt financing as described in Note 6, the Company incurred legal and other related fees. Deferred financing costs incurred in connection with long-term financing amounted to $2,131,150 and are being amortized on a straight-line basis over the stated term of the loan. Amortization expense for the threenine months ended March 31,September 30, 2008 and March 31, 2007 amounted to $193,300$548,492 and $5,053,$231,925, respectively.

Furniture and equipment

Furniture and equipment are summarized as follows:

 September 30, December 31, 
 
March 31,
2008
 
December 31,
2007
  2008 2007 
Vehicles $52,471 $73,331  $43,004 $73,331 
Machinery  632,306  596,505   658,046  596,505 
Furniture and fixtures  415,434  429,148   332,843  429,148 
  1,100,211  1,098,984   1,033,893  1,098,984 
Accumulated depreciation  (428,791) (459,037)  (442,836) (459,037)
 $671,420 $639,947  $591,057 $639,947 

Furniture and equipment are stated at cost. Major renewals and betterments, which prolong the useful life or enhance the value of assets, are capitalized. Depreciation is computed using the straight-line method over the estimated life of five years for machinery and equipment, furniture and fixtures, and vehicles. Depreciation expense for the threenine months ended March 31,September 30, 2008 and 2007 amounted to $16,969$58,693 and $43,474,$133,637, respectively.

Net Loss per Share

Basic Loss per share is computed by dividing net loss attributable to common shareholders for the period by the weighted averageweighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted averageweighted-average number of shares plus the dilutive effect of convertible debt and preferred shares and outstanding options and warrants. Approximately 2221 million and 3 million shares to be issued upon conversion of Series A and Series B respectively, Preferred Shares, respectively, were excluded from the calculation of diluted earnings per share for the periodperiods ended March 31,September 30, 2008 and 2007, respectively, because they were anti-dilutive. Approximately 136 million and 65 million shares to be issued upon conversion of the convertible debentures were excluded from the calculation of diluted earnings per share as of March 31,September 30, 2008 and 2007, respectively, because they were anti-dilutive. Approximately 205 million and 187 million options and warrants to purchase shares of the companies stock were excluded from the calculation of diluted earnings per share as of September 30, 2008 and 2007, respectively, because they were anti-dilutive.

Long-lived assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. When the aggregate undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized, based on the fair value of the asset.

Business risks

The Company is subject to the risks associated with start-up and high growth companies such as the risks of raising adequate capital, producing profitable operations, and operating in various countries throughout the world.

Research and development costs

Research and development costs are expensed as incurred and amounted to $35,024 and $87,566 for the three months ended March 31, 2008 and 2007, respectively.

5

Foreign currency translation

The reporting and functional currency of the Company and its UK Subsidiary is the U.S. Dollar, while the functional currency of the Korea and Taiwan subsidiaries are the Korean Won and the New Taiwanese Dollar, respectively.

The assets and liabilities of the Korea and Taiwan Subsidiaries have been translated into U.S. Dollars at the prevailing period-end rate of exchange, while the related income and expense items were translated at the average rate of exchange during the period. The resulting translation adjustments are accumulated in a separate component of stockholders’stockholders' equity (deficit).

The Company follows Financial Accounting Standards No. 130 (SFAS 130) "Reporting Comprehensive Income." SFAS 130 requires a Company to report comprehensive income (loss) and its components in a full set of financial statements. Comprehensive income (loss) includes the change in equity during a period from transactions and other events and circumstances from non-owner sources, such as unrealized gains (losses) on foreign currency translation adjustments. Changes in unrealized foreign currency translation gains (losses) for the threenine months ended March 31,September 30, 2008 and 2007 amounted to ($16,519)79,195) and $37,258,($51,293), respectively. Accordingly, comprehensive loss for the threenine months ended March 31,September 30, 2008 and 2007 amounted to $1,695,630$5,045,374 and $1,079,465,$13,574,532, respectively.

Fair value of financial instruments

The Company’sCompany's cash, receivables, accounts payable, short-term debt, bonds payable, and the face amount of its convertible debentures represent financial instruments whose carrying amounts reasonably approximate their fair value.

Recent accounting pronouncements

In JulySeptember 2006, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 48,"Accounting for Uncertainty in Income Taxes—an interpretation of FASB Statement No. 109" ("FIN 48"),which provides clarification related to the process associated with accounting for uncertain tax positionsrecognized in consolidated financial statements. FIN 48 prescribes a more-likely-than-not thresholdfor financial statement recognition and measurement of a tax position taken, or expected to be taken,in a tax return. FIN 48 also provides guidance related to, among other things, classification, accounting forinterest and penalties associated with tax positions, and disclosure requirements. FIN 48 is effective for fiscal years beginningafter December 15, 2006. The adoption of this statement did not have a material effect on the Company’sfinancial position or results of operations.

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”), which provides guidancefor measuring the fair value of assets and liabilities, as well as requires expanded disclosures about fair value measurements. SFAS 157 indicates that fair value should be determined based on the assumptions marketplace participants would use in pricing the asset or liability, and provides additional guidelines to consider in determining the market-based measurement . SFAS No. 157 is effective for fiscal years beginning after November 15, 2007.

5


The adoption of this standard did not have a material effect on the Company’s results of operations or financial position.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS 159”). SFAS 159 permits all entities to choose to measure eligible items at fair value at specified election dates. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. The adoption of this standard did not have a material effect on the Company’s results of operations or financial position.

In December 2007, the FASB issued SFAS No. 141(R), “Business Combinations” (“SFAS 141(R)”), which replaces SFAS 141. SFAF 141(R) requires assets and liabilities acquired in a business combination, contingent consideration, and certain acquired contingencies to be measured at their fair values as of the date of acquisition. SFAS 141(R) also requires that acquisition-related costs and restructuring costs be recognized separately from the business combination. SFAS 141(R) is effective for fiscal years beginning after December 15, 2008 and will be effective for business combinations entered into after January 1, 2009.

In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements, an Amendment ARB No. 51” (“SFAS 160”). SFAS 160 clarifies the accounting for noncontrolling interests and establishes accounting and reporting standards for the noncontrolling interest in a subsidiary, including classification as a component of equity. SFAS 160 is effective for fiscal years beginning after December 15, 2008. The Company does not currently have any minority interests.

In March 2008, the FASB issued SFAS No. 161 “Disclosure about Derivative Instruments and Hedging Activities - an amendment of FASB statements No. 133” (“SFAS 161”) which provides revised guidance for enhanced disclosures about how and why an entity uses derivative instruments, how derivative instruments and related hedged items are accounted for under FAS 133, and how derivative instruments and the related hedged items affect and entity’s financial position, financial performance and cash flows. SFAS 161 is effective for the Company’s fiscal year beginning January 1, 2009. The Companydoes not currently have any derivative instruments and is not involved in any hedging activities.

In May 2008, the FASB issued SFAS No. 162 “The Hierarchy of Generally Acceptable Accounting Principles” (“SFAS 162”). SFAS 162identifies the source of accounting principles and the framework for selecting the principles to be used in the preparation of financialstatements of non-governmental entities that are presented in conformity with generally accepted accounting principles in the United States. Thisstatement is effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411,“The Meaning of Present Fairly in Conformity with Generally Accepted Accounting Principles”. Although the Company will continue to evaluatethe application of SFAS 162, the Company does not currently believe the adoption of SFAS 162 will have a material impact on its consolidatedfinancial statements.

Note 2 - Income Taxes

The Company recognizes deferred tax assets and liabilities created by temporary differences between the financial statement and tax basis of assets and liabilities. Deferred tax assets and liabilities are computed on such temporary differences, including available net operating loss carry forwards and tax credits, by applying enacted statutory tax rates applicable to the years when such differences are expected to reverse. A valuation allowance is provided on deferred tax assets to the extent that it is more likely than not that such deferred tax assets will not be realized.

The Company currently operates in the United States, while its Subsidiaries operate in the United Kingdom South Korea, and Taiwan. Operating loss carryforwardscarry forwards in the United States approximated $6,800,000 at December 31, 2007, and can be carried forward for 20 years, expiring in the years 2025-2027. Operating loss carryforwards in the United Kingdom approximated $5,000,000 at December 31, 2007, and can be carried forward indefinitely, provided the Company (i) doesn’tdoesn't cease operations and (ii) doesn’tdoesn't change its business nature, while operating loss carryforwards in South Korea approximated $6,300,000 at December 31, 2007, and expire in the years 2008-2012. At December 31, 2007, the Company has a deferred tax asset of approximately $5,600,000 and has recorded a full valuation allowance against the deferred tax asset resulting from these tax loss carry-forwards.carry forwards.

6

Note 3 - Commitments and Contingencies

Operating Leases

The Company has a lease in Seoul, Korea for its Sales and Administrative office which expires in October 2009.
The Company has a lease in Taipei, Taiwan for its Design and Manufacturing Center which expires in September 2009.
As of December 31, 2007, the minimum future rental commitments under all non-cancelable operating leases with terms greater than one year, are as follows:

Year Ending December 31,      
2008 $100,599  $100,599 
2009 $77,953  $77,953 
 $178,552  $178,552 

Employment contracts

The Company has entered into employment agreements with some of its officers / employees for terms ranging between one and two years. Under the terms of the contracts these officers / employees are entitled to minimum compensation of approximately $274,000 in 2008. Other employees contracts have expired and are employed at will with no minimum compensation.

On August 15, 2007, the Company entered into an agreement with Core Strategies, LLC (“Core Strategies”) which provides services of several Core Strategies partners including Joseph Formichelli as Chief Executive Officer of the Company on a full-time basis, and a marketing and sales executives on a part-time basis. The agreement is effective from August 15, 2007 through August 14, 2009. The Company pays Core Strategies $20,000 per month and has issued 8,000,000 warrants to purchase the Company’s common stock. Effective October 1, 2008, the Company terminated the contract with Core Strategies and hired the CEO and sales executive.

Accrual for Employment Retirement Benefits

The Company has recorded a liability of $94,030$87,556 and $86,683 as of March 31,September 30, 2008 and December 31, 2007, respectively, for employment retirement benefits. The Company believes that thisany liability will not be paid withinsettled with the currentclosing of the Korean office to be completed by year and it has therefore been recorded as a long term liability.end.

Royalty Agreement

On May 18, 2005, the UK Subsidiary entered into a Royalty Agreement with CHL Investment Partnership ("CHL") and Hansen Gray & Company, Inc. ("Hansen Gray"). The terms of the agreement call for a payment of 1.14% and 0.86% of revenue to CHL and Hansen Gray, respectively, once the UK Subsidiary’sSubsidiary's revenue exceeds $25 million. The agreement is terminated once the aggregate payment to CHL and Hansen Gray totals $50 million. During 2005, the Company paid a Royalty Advance to Hansen Gray totaling $500,000.

6


On July 18, 2007, the Company and AMF Capital, Inc. (formerly known as Hansen Gray & Company, Inc) (“AMF”) entered into a Settlement Agreement and Release pursuant to which the Company and AMF resolved certain claims of AMF against the Company. Pursuant to the Settlement Agreement, the Company paid a Royalty Advance of $100,000 in cash to AMF and issued to AMF a warrant to purchase 1,000,000 shares of common stock of the Company at an exercise price of $0.88 per share, and AMF released the Company from any and all claims except for certain specified contractual rights as set forth in the Settlement Agreement. The Company has recorded a full valuation allowance resulting from these prepaid royalties.

CHL is an organization in which Dr. Jeong Hyun Lee (a former Directordirector of the Company) holds an interest in. Hansen Gray is an entity in which Alan Miller (a former Directordirector of the Company) holds an interest in.

Intangible Assets

In April 2007, Celsia acquired certain assets and liabilities together with two sales executives and a thermal management customer base from CheongNam International Co. Ltd. ("CNIT"), a Korean entity, for approximately $70,000. The Company has recorded assets of approximately $88,000, liabilities of approximately $82,000 and intangible asset (which is the value assigned to the acquired customer list) of approximately $64,000. The Company is amortizing this customer list over 36 months.

The Company has also recorded an intangible asset for costs incurred with filing approved patents and trademarks of approximately $34,000. The Company has written off the value of both of these assets in connection with the closing of the Korean subsidiary.

7

Registration Rights

The Company entered into a registration rights agreement with the Preferredholders of the Series B share holdersPreferred shares dated December 16, 2005. Under the terms of the Registration Rights Agreement, the Company was required to use its best efforts to file a Registration Statement covering the underlying Common Stock within six months after the Company’sCompany's Registration Statement on Form SB-2 (SEC File No. 333-128856) was declared effective. The Company was required to maintain the effectiveness of the Initial Registration Statement through the first anniversary of the Closing Date and was to use its best efforts to maintain the effectiveness of the Initial Registration Statement through the second anniversary of the Closing Date. This agreement was amended on May 25, 2007 to reflect the subordination of rights under this agreement to the registration rights agreement entered into by the Company on May 25, 2007 as described below.

The Company entered into a registration rights agreement with the Convertible Debenture Holders dated May 25, 2007 (see Note 6). Under the terms of the Registration Rights Agreement,registration rights agreement, the Company is required to file a Registration Statement (the "Initial Registration Statement") covering the Common Stock (i) into which the Debentures are convertible and (ii) for which the Warrants and Placement Agent Warrants are exercisable (collectively, the “Registrable Securities”) within 30 days of a demand by Debenture Holders or within six (6) months after the Closing Date. If the Initial Registration Statement is not filed on or prior to its Filing Date, or in certain other circumstances, the Company shall pay to each Debenture Holder an amount in cash equal to 1.0% of the aggregate purchase price paid by such Debenture Holder pursuant to the Purchase Agreement for any unregistered securities then held by such Debenture Holder. The Company has fulfilled its requirements by filing the Registration Statement on Form SB-2 (SEC File No. 333-147564) which was declared effective on December 11, 2007.

Litigation

On October 19, 2007, the Company’sCompany's former President, CEO, and Board of Director, filed a lawsuit in the Miami-Dade County Circuit Court claiming failure to pay bonses,bonuses, severance, and other benefits in connection with his previously reported termination by the Company. The Company has filed a motion to Compel Arbitration and Stay Proceedings as provided by the employment contract with the Company. On April 16, 2008, the court granted the Company’sCompany's motion and ordered (i) that the Plaintiff commence arbitration in accordance with the terms of the employment agreement within six (6) months of the date of the order and (ii) all proceedings are stayed until the conclusion of the arbitration proceedings.  Pursuant to the court order, if arbitration is not timely commenced the action will be dismissed. The Company believes the employee’semployee's claims are without merit and intends to defend the action vigorously. The settlement of this action is not expected to have a material impact on the Company’sCompany's financial position.

Note 4 - Bond payable

The bond payable (Won 300 million) at March 31,September 30, 2008 and December 31, 2007, was issued to a third party in December 2002 and matures in December 2007. The bond carries no interest and has been discounted using a 7% interest rate. The bond payable is summarized as follows:

 September 30, December 31, 
 
March 31,
2008
 
December 31,
2007
  2008 2007 
Face Amount $303,475 $322,582  $248,707 $322,582 
Less: Discount  (93,926) (93,926)  (93,926) (93,926)
Plus: Amortization of discount  93,926  93,926   93,926  93,926 
              
Carrying value $303,475 $322,582  $248,707 $322,582 

Note 5 - Notes Payable

On February 20, 2007 and April 20, 2007, the Company issued Secured Convertible Promissory Notes (the “Notes”) in an aggregate principal amount of $1,000,000 and $150,000, respectively, to certain purchasers (the “Noteholders”) pursuant to the terms of Securities Purchase Agreements dated as of February 20, 2007 by and between the Company and the Noteholders. The Notes carry an annual interest rate of 10%, with all principal and accrued interest being due and payable on June 20, 2007; provided, however, that upon the terms and subject to the conditions of the Notes, all outstanding principal and interest on the Notes will automatically convert into securities of the Company issued pursuant to a Company financing meeting certain conditions (a “Qualified Financing”), if such Qualified Financing is effectuated on or prior to June 20, 2007. All principal and accrued interest on the Notes shall become payable prior to June 20, 2007 upon certain events of default relating to, among things, the bankruptcy or dissolution of the Company, the sale of substantially all of the Company’s assets and certain breaches by the Company of the terms and conditions of the Notes and related agreements. The obligations evidenced by the Notes were secured by a pledge of substantially all of the Company’s assets, including the capital stock of Celsia Technologies UK Limited and Celsia Technologies Korea, Inc. In connection with the issuance of the Notes, the Company’s former Chief Executive Officer and former Chief Financial Officer had agreed to transfer approximately 735,000 shares of Company common stock held by such executives to the Noteholders in the event that a Qualified Financing does not occur on or prior to June 20, 2007.

On May 25, 2007, the Company issued Convertible Debentures which met the conditions of a Qualified Financing. The Notes, totaling principal of $1,150,000, interest of $27,847, and a 10% premium on principal totaling $115,000, were automatically converted into the Convertible Notes (see Note 6). Upon completion of the transaction, the 735,000 shares of Company common stock pledged by the Company’sCompany's former Chief Executive Officer and former Chief Financial Officer were returned to them.

87


Note 6 - Convertible Debentures

On May 25, 2007, the Company issued 8% Secured Convertible Debentures due May 25, 2010 (the “Debentures”) in the aggregate principal amount of $8,142,847 to certain individuals and entities, together with warrants exercisable for a total of 70,752,778 shares of the Company’s common stock at a price of $0.144, for an aggregate of $6,850,000 in cash and the surrender of previously outstanding promissory notes of the Company totaling $1,292,847 (see Note 5). The Company used the Black Scholes option-pricing model to value the warrants issued to the Debenture Holders and applied it to the principal amount to determine the convertible debt discount. The Company will amortize the discount over the life of the Debenture (36 months).

On August 17, 2007, the Company issued an additional 8% Secured Convertible Debenture due May 25, 2010 in the principal amount of $350,000, together with a warrant to purchase 2,800,000 shares of the Company’s common stock at a price of $0.144, for $350,000 in cash, on the same terms as the Company’s debentures and warrants issued on May 25, 2007.

On January 1, 2008, the Company elected to acreteaccrete to, and increase, the outstanding principal amount due under the Debenture by $404,936 pursuant to the terms of the Debenture.

The convertible debentures payable is summarized as follows:

 September 30,  December 31,  
 
March 31,
2008
 
December 31,
2007
  2008 2007 
Face Amount $8,897,783 $8,492,847  $8,897,783 $8,492,847 
Less: Discount  (5,062,256) (5,062,256)  (5,062,256) (5,062,256)
Plus: Amortization of discount  1,393,520  970,205   2,230,152   970,205  
              
Carrying value $5,229,047 $4,400,796  $6,065,679 $4,400,796 

The sale of Debentures and Warrants (the “Debenture Offering”) was effected pursuant to a Securities Purchase Agreement dated as of May 25, 2007 between the Company and the Debenture Holders (the “Purchase Agreement”). In connection with the Debenture Offering, the Company entered into a Security Agreement and Registration Rights Agreement, each dated as of May 25, 2007, with the Debenture Holders (see Note 3).

In connection with the Debenture Offerings, the placement agents (i) received a cash fee of approximately $618,000 and (ii) are entitled to receive warrants to purchase 5,120,000 shares of the Company’s common stock at a price of $0.144. The Company has recorded payments to the placement agents as a deferred cost (see Note 1).

As part of the debt financing, each holder of Series A & B Preferred Stock who certified their status as an accredited investor was issued 2.19 shares of Common Stock for each share of Preferred Stock held. The Company has recorded a financing expense of $6,060,564 representing the fair value of the 50,504,696 shares of Common Stock issued as an inducement to the Series A & B Preferred Shareholders to consent to the convertible debenture. As of December 31, 2007, 46,517,737 shares of Common Stock have been issued and the remaining 3,986,959 shares have been recorded as Common Stock subscribed. As part of the same consent, the holders of the Series A & B Preferred Shareholdersshares agreed to modify the terms of the preferred stock to eliminate their seniority to the Debenture holders in regards to the sale or liquidation of the Company, forfeit any unpaid and undeclared dividends through May 24, 2007, lower the dividend rate on the Series A Preferred Stock to two percent per annum (2%) going forward, and eliminate certain additional rights of the preferred stock. In addition, the holders of the Series A & B Preferred Shareholdersshares waived any future anti-dilution rights.

Upon issuing the Debentures, the Company triggered certain anti-dilution provisions in the Company’sCompany's warrants which lowered the conversion price and increased the number of shares the warrant is convertible for. The Company used the Black-Scholes option-pricing model to determine the fair market value of the adjusted warrants and recorded a deemed dividend of $652,318 (see note 7).

The Debenture Holders shall be entitled to receive interest on the aggregate unconverted and then outstanding principal amount of their Debentures at the rate of 8% per annum, payable quarterly, in cash or Common Stock at the discretion of the Company, and subject to certain limitations and restrictions. The Debentures are secured by substantially all of the Company’s assets. The Debenture Holders have the right to convert the Debentures at any time into shares of Common Stock at an initial conversion price of $0.125. The exercise price of the Warrants and Placement Agent Warrants are $.144 per share. The initial conversion price of the Debentures and the exercise price of the Warrants and Placement Agent Warrants are subject to adjustment upon certain events.

9

The Company triggered adjustments to the conversion price of the Debenture and the exercise price of the Warrants as a result of the Company’sCompany's financial results for the period ending September 30, 2007, which became effective November 15, 2007. The Debenture Holders now have the right to convert the Debentures at any time into shares of Common Stock at a conversion price of $0.0625. The number of Warrants issued to the Debenture Holders and the Placement Agents increased to 147,105,556 and 10,240,000, respectively, and the exercise price was reduced to $0.072 per share.

The Company used the Black Scholes option-pricing model to value the adjusted warrants issued to the Debenture Holders and applied it to the principal amount to determine the convertible debt discount which totaled $5,062,256. The Company will amortize the discount over the life of the Debenture (36 months). During the threesix months ended March 31,June 30, 2008, the Company amortized $423,316$836,632 of the debt discount into interest expense. As a result of the adjustment to the conversion price, the Company has recognized a beneficial conversion feature and recorded a Financing Expense totaling $3,430,591 during the year ended December 31, 2007.

On March 26, 2008, the Company obtained consent from more than 70% of the Debenture Holders to modify the terms of the Debentures to provide that, in lieu of making the interest payments due thereunder in cash or in shares of common stock of the Company on the interest payment due dates, the interest payments shall accrue and be paid in full in cash on May 25, 2010, the Debenture maturity date.  As an incentive to provide the consent, the Company shall distribute to the Debenture Holders a one time distribution equal to the value of 2% of the outstanding principal amount due under the Debentures as of March 31, 2008 totaling approximately $178,000, which will be paid in cash on the maturity date.   Each Debenture Holder shall have the right, in its sole discretion, to convert any accrued but unpaid interest on the principal amount due under the Debentures into shares of common stock of the Company at the applicable Interest Conversion Rate at any time prior to the maturity date.

During the nine month period ended September 30, 2008, the Company issued 160,000 shares of common stock for the conversion of $10,000 in Debentures principal and issued 97,925 shares of common stock for the conversion of $2,350 in accrued interest.

Note 7 - Stockholders’Stockholders' equity

Capital stock

At March 31,September 30, 2008 and December 31, 2007, the Company had an authorized number of shares of 500,000,000750,000,000 Common Shares and 100,000,000 of Preferred Shares, 30,000,000 of which has been designated as Preferred Series A Shares and 7,000,000 of which has been designated Preferred Series B Shares. As of March 31,September 30, 2008, the total issued and outstanding shares were 85,565,71386,561,449 Common Shares, 22,032,96321,306,261 Preferred Series A Shares, and 3,063,402 Preferred Series B Shares. As of December 31, 2007, the total issued and outstanding shares were 85,273,680 Common Shares, 22,320,598 Preferred Series A Shares, and 3,063,402 Preferred Series B Shares.

8


During the years ended December 31, 2007, 740,907 shares of Preferred Series A were converted to Common Shares, respectively, at a rate of 1:1.

During the threenine months ended March 31,September 30, 2008, 287,6351,014,337 shares of Preferred Series A were converted to Common Shares, respectively, at a rate of 1:1.

Share Exchange Agreement and Series A Offering

Effective as of July 11, 2005, the Company issued 20,995,239 shares of Series A Preferred Stock, together with warrants exercisable for a total of 6,441,895 shares of the Company’sCompany's common stock at prices ranging from $0.88 - $1.32, to various parties in exchange for approximately $12.48 million in cash (at a cash price of $0.88 per share of Series A Preferred Stock) and the transfer of $4.6 million of previously issued promissory notes issued by various parties. (These transactions are collectively referred as the “Series A Offering").

In connection with the Series A Offering, the Company entered into a Registration Rights Agreement dated as of July 11, 2005 with the Company’sCompany's shareholders, Series A Shareholders, and certain additional parties. Under the terms of the Registration Rights Agreement, if a registration statement is not filed within 60 days of July 11, 2005 or declared effective within 120 days of July 11, 2005 (each a "Non-registration Event"), then for each 30 day period during the pendancy of such a Non-Registration Event, the company is required to pay to the selling shareholders liquidated damages in an amount equal to one percent (1%) of the aggregated price such selling shareholders paid for the Company’sCompany's series A Preferred stock (deemed to be $0.88 per share), which the company may pay in cash or additional shares of series A Preferred Stock (valued at $0.88 per share), at the company’scompany's option. The registration statement was filed on October 6, 2005 and was declared effective in April 2006. On August 10, 2006, the Company issued 970,550 Series A Preferred Shares valued at $902,611 to Preferred Series A Share Holders in settlement of the Non-Registration Events. This agreement was amended on May 25, 2007 to reflect the subordination of rights under this agreement to the registration rights agreement entered into by the Company on May 25, 2007 (see Note 3).

Terms of Series A Preferred

Subject and subordinate to the liquidation rights of the Company’s Secured Convertible Promissory Noteholders, the holders of the Series A Preferred shall be entitled to receive in preference to the holders of the Series B and Common Stock a per share amount equal to $0.88 plus any accrued, unpaid dividends, in the event of any sale or dissolution of the Company. The holders of the Series A Preferred have the right to convert the Series A Preferred at any time into shares of Common Stock at an initial conversion rate of 1:1, as defined. At the option of the Company, if certain criteria as defined in the agreement are met, the Series A Preferred can be converted into Common Stock.

Prior to May 25, 2007, the holders of Series A Preferred Stock were entitled to receive cumulative, compounding dividends at a rate of eight percent (8%) per annum as, when and if declared by the Board of Directors of the Company. The dividends may be paid in cash or shares of Series A Preferred Stock (valued at original issue price) at the sole discretion of the Company. Holders of Series A Preferred Stock also receive on an as-converted basis any distributions paid on the common stock. No dividends may be paid on common stock unless all unpaid cumulative dividends on the Series A Preferred Stock are paid. On August 10, 2006, the Company issued approximately 1,700,000 shares of Series A Preferred Stock as dividends to all holders of record on July 11, 2006, valued at approximately $1,500,000. As of May 25, 2007, the Series A Preferred Stock consented to waive any unpaid and undeclared dividends which resulted in the elimination of approximately $1,172,000 in accumulated, unpaid and undeclared dividends (see Note 6). In addition, the Series A Preferred Shareholders consented to lower the compounding dividend rate to two percent (2%) per annum. As of March 31, 2007, accumulated, undeclared dividends on the Series A Preferred Shares totaled approximately $339,400.

10

Terms of Series B Preferred

Subject and subordinate to the liquidation rights of the Company’s Secured Convertible Promissory Noteholders and Series A Preferred Stock, the holders of the Series B Preferred shall be entitled to receive in preference to the holders of the Common Stock a per share amount equal to $1.00, in the event of any sale or dissolution of the Company. The holders of the Series B Preferred have the right to convert the Series B Preferred at any time into shares of Common Stock at an initial conversion rate of 1:1, as defined. At the option of the Company, if certain criteria as defined in the agreement are met, the Series B Preferred can be converted into Common Stock. Holders of the Series B Preferred Stock receive on an as-converted basis any distributions paid on the Common Stock.

Stock Compensation

Through March 31,September 30, 2008 and 2007, the Company has granted approximately 4.6 and 6.6 million respectively, of its common stock to employees and others, of which approximately 4.4 and 4.3 million, respectively, common shares have vested. These shares issuances were valued between $0.07-0.50 based upon management’smanagement's estimate of the fair value of the common stock on the date of issuance. These stocks grants have certain vesting provisions through May 2009. For the threenine months ended March 31,September 30, 2008 and 2007, approximately 0 and 78,000166,000 shares, respectively, vested and a charge to compensation expense of $4,750$14,250 and $51,838,$37,922, respectively, was recorded. The remaining unvested shares valued at approximately $23,750$14,250 are being amortized over their respective vesting periods.

Employee Stock Options

On January 1, 2006, the Company adopted the fair value recognition provisions of Statement of Financial Accounting Standards (SFAS) No. 123R, “Share-Based Payment,” using the modified prospective method. For the threenine months ended March 31,September 30, 2008 and 2007, the Company recognized stock-based compensation of $51,882$148,814 and $41,603,$116,842, respectively. The Company considers voluntary termination behavior as well as trends of actual option forfeitures when estimating its forfeiture rate. Given the limited history of outstanding options, the Company has estimated a 0% forfeiture rate and has only recorded actual forfeitures as incurred.

Stock options issued under the Company’s Long-term Incentive Plans are granted with an exercise price equal or greater than the market price of the Company’s stock at the date of grant and expire ten years from the date of grant. These options generally vest over a two- or three-year period. During the threenine months ended March 31,September 30, 2008 and 2007, the Company issued 2.2 million and 0 options, respectively, to purchase common stock.stock which had a fair market value of $32,780 and $0, respectively, which was calculated using the Black-Scholes option-pricing model.

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing method. Given its limited trading history, the Company used volatility from companies in the same industry. The Company estimated the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The Company has not made any dividend payments on common stock nor does it have plans to pay dividends in the foreseeable future. The following assumptions were used to estimate the fair value of options granted during the year ended December 31, 2007 and 2006noted periods using the Black-Scholes option-pricing model:

2007
Risk free interest rate7.33-8.25%
Expected Term (years)5
Expected volatility100.00%
Dividend Yield0.00%
9


  2008 2007 
Risk free interest rate  5.00% 7.33-8.25%
Forfeiture Rate  0.00% 0.00%
Expected Term (years)  5  5 
Expected volatility  100.00% 100.00%
Dividend Yield  0.00% 0.00%

Information about all employee options outstanding is as follows:

For the three months ended March 31,  
2008
 
  2007
 
For the nine months ended September 30,  
2008
 
2007
 
 
 
 
Weighted Average
 
 
 
Weighted Average
 
 
Shares
 
Weighted Average Exercise Price
 
Shares
 
Weighted Average Exercise Price
 
 
Shares
 
Exercise Price
 
Shares
 
Exercise Price
 
                  
Options Outstanding at beginning of period  16,117,500 $0.15  3,176,015 $0.79   16,117,500 $0.15  3,176,015 $0.79 
Granted  0 $-  0 $-   2,200,000 $0.0625  0 $- 
Cancelled  0 $-  (104,000)$0.88   0 $-  - $- 
Options Outstanding at end of period   16,117,500 $0.15  3,072,015 $0.79   18,317,500 $0.14  3,176,015 $0.79 

As of September 30, 2008, a total of 7,909,532 employee stock options are exercisable and the unamortized stock compensation is $224,542.
11


Warrants to Purchase Common Stock

During 2005, the Company issued various warrants to various parties in connection with the Series A and B Offerings. On May 25, 2007, upon issuing the Debentures, the Company triggered certain anti-dilution provisions in these warrant agreements which lowered the conversion price and increased the number of shares the warrant is convertible for. The Company used the Black-Scholes option-pricing model to determine the fair market value of the adjusted warrants and recorded a deemed dividend of $652,318. The tables below show the effect of the repriced warrants and increase in the number of shares.

On September 11, 2006, the Company issued warrants to purchase 1,500,000 of Celsia common stock to a third party as part of a distribution agreement. As part of the same agreement, the Company received warrants to purchase 500,000 shares of the distributors common stock. The warrants vest 25% in December 2006, 25% in December 2007, and 50% contingent upon acheivementachievement of volume thresholds. The agreement was executed with the intention that the value of each warrant to be materially similar in value. Management has estimated the fair market value of both issuances using the Black-Scholes Option pricing model and has valued the warrant issuance to them at approximately $220,000. The Company has recorded an expense totaling approximately $139,000 related to this issuance as of December 31, 2007. No value was assigned to the warrants received by the Company.

On May 25, 2007, the Company issued warrants to purchase 70,752,778 shares of Celsia common stock to the Debenture Holders (see Note 6). The Company valued the warrants to determine the discount on the debenture. In addition, the Company become obligated to issue warrants to purchase 5,120,000 shares of Celsia common stock to the Placement Agents and recorded $355,328 as deferred charges.

On July 18, 2007, the Company issued AMF Capital, Inc. a warrant to purchase 1,000,000 shares of common stock of the Company at an exercise price of $0.88 per share as part of a settlement (see Note 3). The Company recorded an expense of $32,700 for the issuances.

On August 17, 2007, the Company issued warrants to purchase 2,800,000 of Celsia common stock to the Debenture Holders (see Note 6). The Company valued the warrants to determine the discount on the debenture.

The Company triggered adjustments to the exercise price of the Debenture Warrants as a result of the Company’sCompany's financial results for the period ending September 30, 2007, which became effective on November 15, 2007. The number of Warrants issued to the Debenture Holders and the Placement Agents increased to 147,105,556 and 10,240,000, respectively, and the exercise price was reduced to $0.072 per share. The Company recorded a deferred charge of $521,216 for the additional warrants issued to the placement agent.

During the year ended December 31, 2007, the Company issued warrants to purchase 1,300,000 shares of common stock to a consultant and recorded $59,410 as a consulting expense. During the year ended December 31, 2007, the Company issued 1,440,000 shares of common stock and warrants to purchase 720,000 in satisfaction of a $90,000 outstanding liability.

A summary of the issued and outstanding warrants are as follows:

Old
Exercise
Price
 
Old
# of Warrants Outstanding
 
Anti-Dilution
Exercise
Price
 
Anti-Dilution
# of Warrants Outstanding
 
# of Warrants
Exercisable 
 
Expiration
Date
 
            
0.072  720,000  n/a  n/a  720,000  December 2012 
0.11  1,300,000  n/a  n/a  1,300,000  December 2012 
0.144  78,672,778 $0.072  157,345,556  157,345,556  May 2012 
0.32  1,500,000  n/a  n/a  750,000  September 2011 
0.88  1,000,000  n/a  n/a  1,000,000  July 2012 
0.88  681,018 $0.144  681,018  681,018  July 2009 
0.88  1,186,820 $0.36  2,862,308  2,862,308  July 2010 
1.09  1,097,142 $0.36  2,646,027  2,646,027  July 2010 
1.10  2,759,357 $0.45  6,789,387  6,789,387  July 2010 
1.32  2,759,357 $0.53  6,882,126  6,882,126  July 2010 
1.50  772,190 $0.60  1,941,836  1,941,836  December 2010 
$3.00  765,850 $1.16  1,986,069  1,986,069  December 2010 
Old
 
Old
 
Anti-Dilution
 
Anti-Dilution
 
 
 
 
 
Exercise
 
# of Warrants
 
Exercise
 
# of Warrants
 
# of Warrants
 
Expiration
 
Price
 
Outstanding
 
Price
 
Outstanding
 
Exercisable
 
Date
 
            
$    0.072  720,000  n/a  n/a  720,000  December 2012 
$      0.11  1,300,000  n/a  n/a  1,300,000  December 2012 
$    0.144  78,672,778 $0.072  157,345,556  157,345,556  May 2012 
$      0.32  1,500,000  n/a  n/a  750,000  September 2011 
$      0.88  1,000,000  n/a  n/a  1,000,000  July 2012 
$      0.88  681,018 $0.144  681,018  681,018  July 2009 
$      0.88  1,186,820 $0.36  2,862,308  2,862,308  July 2010 
$      1.09  1,097,142 $0.36  2,646,027  2,646,027  July 2010 
$      1.10  2,759,357 $0.45  6,789,387  6,789,387  July 2010 
$      1.32  2,759,357 $0.53  6,882,126  6,882,126  July 2010 
$      1.50  772,190 $0.60  1,941,836  1,941,836  December 2010 
$      3.00  765,850 $1.16  1,986,069  1,986,069  December 2010 
         181,134,327  184,904,327    

Warrants to Purchase Preferred Stock

During 2005, the Company issued various warrants to placement agents in connection with the Series A and B Offerings. A summary of these warrants are as follows:

Old
Exercise
Price
 
Old
# of Warrants Outstanding 
 
New
Exercise
Price  
 
New
# of Warrants
Outstanding 
 
# of Warrants
Exercisable 
 
Expiration
Date 
 
$ 0.88  1,364,528 $0.144  1,364,528  1,364,528  July 2010 
$1.50  210,000 $0.144  210,000  210,000  December 2010 
Old
 
Old
 
New
 
New
 
 
 
 
 
Exercise
 
# of Warrants
 
Exercise
 
# of Warrants
 
# of Warrants
 
Expiration
 
Price
 
Outstanding
 
Price
 
Outstanding
 
Exercisable
 
Date
 
$      0.88  1,364,528 $0.144  1,364,528  1,364,528  July 2010 
$      1.50  210,000 $0.144  210,000  210,000  December 2010 
         1,574,528  1,574,528    
 
1210


Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of OperationsOperations
 
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.
Forward-Looking Statements
 
Certain of the matters discussed in this report, including, without limitation, matters discussed under this Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may constitute forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and are subject to the occurrence of certain contingencies which may not occur in the time frames anticipated or otherwise, and, as a result, could cause actual results to differ materially from such statements. In some cases, you can identify forward-looking statements when used in this Form 10-Q or other filings by the Company with the Securities and Exchange Commission, in our press releases or other public or shareholder communications, or in oral statements made with the approval of an authorized Company officer by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of such terms and other comparable terminology.

We caution readers not to place undue reliance on any forward-looking statements, which speak only as of the date made, and advise readers that forward-looking statements involve various risks and uncertainties. We do not undertake, and specifically disclaim, any obligation to update any forward-looking statements to reflect occurrences or unanticipated events or circumstances after the date of such statement.

OverviewBusiness
 
Celsia’sOur business strategy is to become a leader in researching, developing and commercializing next-generation cooling solutions which are focused on the computer, flat panel display, LED-lighting, and communications industries. We develop, manufacture, market, sell and/or license our patented thermal management products and technology.technology to original equipment manufacturers (OEMs), third party design/manufacturers and to total solution providers in the thermal management business. We believe that our products absorb, transport and dissipate heat more efficiently than current heat-pipe/heat-sink cooling solutions. Our unique cooling device uses patented combinations of liquid and vapor layers to manage liquid and vapor at very high speeds through micro-channels within the assemblies.
 
We develop and commercialize technology and have succeeded in achieving several design wins with major suppliers of graphics and memory solutions sold at key OEMs.both retail and into branded end products. Celsia has partnered with a major device manufacturer and our NanoSpreaders™ technology has been successfully demonstrated at this manufacturer’s recent technical forum on cooling solutions. We engage with key OEM’ssuch companies who are findingfind our technology an attractive solution to their thermal management problems.needs. To improve this communications with future clients we have engaged and trained a rep sales force to more thoroughly cover both the USA and Europe. We believe that we provide better performance than competing technologies at a competitive price. ThisUse of our products allows the OEM’sOEMs and solution providers to either offer higher performance or to run their systems cooler. We expect design wins in all of our key target markets, which include LED’s, Graphics Chips,graphics chips, high end CPUs, communications equipment and memory applications.
 
13


We expect our product development, and project management activities to continue to be driven by commercial opportunities and undertaken as a result of potential customers requesting test units. The test orders that we receive from potential customers are fulfilled either by (1) modification of already commercialized products or (2) new solutions designed together with input from the potential customer. The majority of our R&D resources are dedicated to customer projectsmeeting and quoting on the potential customer’s requirements with an objective of commercial opportunities which will be available in quantities, to end users, within a three to four quarter time period.
We are managed by a team of professionals with significant operational and thermal solutions experience and knowledge. Our executive officers also have extensive experience with industry leaders in all of the major market segments we are engaged with, where improved cooling of electronic devices is a major competitive advantage. We intend to leverage this extensive experience and our relationships within such sectors to execute on our core strategy and build significant long-term value for the design of products with commercial opportunities.our stockholders.
11

 
In December 2007, we relocated our engineering and pilot line facilities from Korea to Taiwan. Our Korean staff and facilities were downsized to a sales and administrative support function only.only and these functions will be totally phased out by the end of our 2008 fiscal year. The net result isrelocation to Taiwan resulted in a more responsive unit in Taiwanoperating at lower costs. Any additional capital expenditures over the next twelve months will be focused on complementing this newthe Taiwan pilot plant with specific volume related equipment and on specific research and development related test equipment. All investments will be driven by commercialization opportunities, customer driven projects, and/or commercial volumes.
 
Our product test orders have led to several related test product deliveries, as well as commercial orders. Test products are used by potential customers to examine our products’ features and compatibility with customer products. Although such testing procedures can involve numerous steps and significant timelines, in several instances our test products have advanced beyond the test phases and been incorporated into commercial products. The mix between sample order deliveries and commercial deliveries continues to increase in favor of commercial deliveries. Once our products are shipped to our customers, our Company haswe have no additional commitment in order to recognize revenues.
 
Results of Operations
Three Months Ended March 31,September 30, 2008 Compared to Three Months Ended March 31,September 30, 2007
 
The Company hasWe produced revenues of $305,688$228,157 for the three months ended March 31,September 30, 2008 compared to $99,323$208,266 for the three months ended March 31,September 30, 2007. The increase in revenues areis a result of customers paying for test samples and commercial deliveries.deliveries of our NanoSpreaders™. Cost of sales for the three months ended March 31,September 30, 2008 were $294,725$255,196 compared to $166,538$329,089 for the same period last year. This is attributable to increased production activity originating from an increasing demand for the fiscal year 2007. We have decreased our products.cost of sales and narrowed our loss in profit margin because we have scaled down the sales of low margin thermal management commodity products that was part of a Korean business acquisition in April 2007.
 
We are currently operating with strict cost controls in order to manage our commercialization process. A majority of our expenses for the three months ended March 31,September 30, 2008 and 2007 were from selling and administrative expenses. The selling and administrative expenses for the three months ended March 31,September 30, 2008 were $740,555$815,008 compared to $956,962$1,057,060 for the same period last year.in fiscal 2007. The main costs are personnel costs, professional fees, and travel expenses. The decrease in expenses is due to a company wide initiative to reduce expenses and personnel. 
Nine Months Ended September 30, 2008 Compared to Nine Months Ended September 30, 2007
We produced revenues of $948,203 for the nine months ended September 30, 2008 compared to $506,921 for the nine months ended September 30, 2007. The increase in revenues is a result of customers paying for test samples and commercial deliveries of our NanoSpreaders™. Cost of sales for the nine months ended September 30, 2008 were $997,637 compared to $877,027 for the same period for the fiscal year 2007. This increase is attributable to increased production activity originating from an increasing demand for our products.
12

We are currently operating with strict cost controls in order to manage our commercialization process. A majority of our expenses for the nine months ended September 30, 2008 and 2007 were selling and administrative expenses. The selling and administrative expenses for the nine months ended September 30, 2008 were $2,235,824 compared to $2,559,364 for the same period in fiscal 2007. The main costs are personnel costs, professional fees, and travel expenses. The decrease in expenses is due to a company wide initiative to reduce expenses and personnel.
 
Liquidity and Capital Resources
 
Our main source of liquidity and funding for our operations has historically been from monies raised from various financings. During fiscal 2007, we raised an aggregate amount of $8,000,000$8,492,847 in cash through the issuance of the Debenturessecured convertible debentures, which become due in May 2007, which was later increased by $350,000 in August 2007.2010. At March 31,September 30, 2008, our operational cash outflow was approximately $300,000$260,000 per month. Our main use of cash relates to product development driven by customer projects and general and administrative expenses.
14

On May 25, 2007, the Company obtained additional funds through the issuance of its Debentures in the aggregate amount of $8,142,847, of which $6,850,000 was paid in cash and the remainder through the surrender of previously outstanding promissory notes of the Company. On August 17, 2007, we issued an additional Debenture in the principal amount of $350,000 on the same terms as the Company’s debentures issued on May 25, 2007. Both issuances were accompanied by warrants to purchase the Company’s common stock. The Debentures mature and become are due on May 25, 2010.

In connection with the debenture financing,order to reduce our cash outflows, during March 2008, we incurred legal, due diligence, and placement agent fees of approximately $2,131,000. We have recorded these expenses as deferred charges and these expenses will be amortized over the length of the loan period. We have recorded amortization of deferred financing costs of approximately $193,000 for the three months ended March 31, 2008.  Additionally, we recorded an interest expense of approximately $633,000 for the three months ended March 31, 2008. Approximately $423,000 in interest expense results from amortization of a debt discount recorded based upon the fair value of the warrants issued to the debenture holders and has no cash impact on us. The remaining $210,000 pertains to the debenture financing.
On March 26, 2008, the Company obtained consent from more than 70% of the Debenture Holdersour debenture holders to modify the terms of the Debenturesdebentures to provide that, in lieu of making the interest payments due thereunder in cash or in shares of our common stock of the Company on the interest payment due dates, the interest payments shall accrue and be paid in full in cash on May 25, 2010,at the Debenture maturity date.date of the debentures. As an incentive to provide the consent, we agreed to pay the Company shall distribute todebenture holders, at the Debenture Holders a one time distributionmaturity date of the debentures, an amount in cash equal to the value of 2% of the outstanding principal amount due underof the Debenturesdebentures as of March 31, 2008 totaling(or approximately $178,000, which will be paid in cash on the maturity date.$178,000). Each Debenture Holder shalldebenture holder continues to have the right, in its sole discretion, to convert any accrued but unpaid interest on the principal amount due under the Debenturesdebentures into shares of our common stock of the Company at the applicable Interest Conversion Rateinterest conversion rate at any time prior to the maturity date.
 
Based on our current operating plan, we anticipate using our cash mainly to continue commercialization efforts and to expand the distribution network for our technology solutions. The main uses for our cash uses will be for sales and marketing, general and administrative, and research and development expenses. Investments will be focused on product development and manufacturing. All investments will be driven by commercialization opportunities. TheOur total cash needneeds for the next twelve months following October 1, 2008 is estimated to be approximately $2.7 million, starting at April 1, 2008. The main portion of the cash need is for sales activities, operating expenses, cost of sales, and a smaller portion is for investments in manufacturing and R&D. We expect to fund these activities through the cash received from the debenture financing and cash generated from operations.$1.6 million. We currently believe that our cash balances and anticipated cash flows from operations will be sufficient to meet our normal operating needs through December 2008.January 2009. We haveexpect to fund our operations, including capital costs and the costs of any necessary implementation of technological innovations, through cash generated from operations and from the proceeds of additional financing that we are in the process of seeking to obtain.   There can be no assurance that we will be successful in raising the necessary financing that we need to continue our operations. Our subsidiary has a $322,582$248,707 note payable to a strategic partner that matured in 2007. As of the date of this filing, no payment demand has been received.2007 and remains unpaid.
 
1513


The ratio between current assets and current liabilities at March 31,September 30, 2008 was approximately 1.49.0.65 to 1.0.
 
Our future liquidity and capital resource requirements will depend on many factors, including, but not limited to the following trends and uncertainties we face:
 
 ·Our operations continue to depend upon the continuing business of our existing customers and our ability to attract new customers;
 
 ·We experience competition in our industry and continuing technological changes;
 
 ·We compete with a number of larger companies who have greater resources than those of ours; and
 
 ·We compete on the basis of industry knowledge, products, services, price, technological advances and system functionality and performance.performance; and
·Our ability to raise additional capital for operations.
 
Critical Accounting Policies and Estimates
 
We prepare our financial statements in conformity with accounting principles generally accepted in the United States of America, which require management to make estimates and assumptions that affect the reported amounts in the financial statements. Although these statements are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. Significant estimates required to be made by management include the valuation of 1equity1) equity securities issued, 2) registration rights, 3) intangible assets, and 4) accounting for convertible debentures.
 
Recent Accounting Pronouncements
 
See Note 1 of the Notes to Consolidated Financial Statements included in Item 1 of this Quarterly Report for Recent Accounting Pronouncements.
 
Off-Balance Sheet Arrangements
 
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
 
Market Risks
 
The Company operatesWe operate in the United States, the United Kingdom, Taiwan, and South Korea, each of which has its own currency. This may cause the Companyus to experience and be exposed to different market risks such as changes in interest rates and currency deviations.
 
Our business is not seasonal and the effect of inflation on our revenue and operating results was not significant.
14


Item 3.
Quantitative and Qualitative Disclosures about Market Risk.Risk.
 
We are a smallsmaller reporting company and this Item is not applicable to us.
 
16

Item 4. T.
Controls and Procedures.Procedures.
 
Evaluation of disclosure controlsDisclosure Controls and proceduresProcedures
 
We maintain “disclosureDisclosure controls and procedures” as defined in Rules 13a-15(e) are controls and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”),other procedures that are designed to ensure that information required to be disclosed by us in company reports we filefiled or submitsubmitted under the Securities Exchange Act of 1934, or the “Exchange Act,” is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms,forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that such information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our principalchief executive officer and principalchief financial officer, as appropriate to allow timely decisions regarding required disclosure.

In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.
 
Our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31,September 30, 2008 and concluded that the disclosure controls and procedures were not effective, because certain deficiencies involving internal controls constituted a material weakness as discussed below. The material weakness identified did not result in the restatement of any previously reported financial statements or any other related financial disclosure, nor does management believe that it had any effect on the accuracy of our Annualfinancial statements for the current reporting period.
Management’s Report on Form 10-KInternal Control Over Financial Reporting
Management is responsible for establishing and maintaining adequate “internal control over financial reporting” as defined in Rules 13a-15(f) and 15d-15(f) under the year ended December 31, 2007, as filedExchange Act. Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:
(i)pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
(ii)provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
(iii)provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.
15


Our management, including our principal executive officer and principal financial officer, has used the Securities and Exchangeframework set forth in the report entitled “Internal Control—Integrated Framework” published by the Committee of Sponsoring Organizations of the Treadway Commission to conduct an evaluation of the effectiveness of our internal control over financial reporting. Based on February 28, 2008 (the “Annual Report”).

The Company’s material weakness in its evaluation, our management concluded that our internal control over financial reporting was not effective because certain deficiencies involving internal controls constituted a material weakness. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that we identifiedthere is a reasonable possibility that a material misstatement of our interim financial statements will not be prevented or detected on a timely basis.
Our material weakness in our Annual Reportinternal control over financial reporting relates to the monitoring and review of work performed by our Chief Financial Officer in the preparation of audit and financial statements, footnotes and financial data provided to the Company’sour registered public accounting firm in connection with the annual audit. All of our financial reporting is carried out by our Chief Financial Officer. This lack of accounting staff results in a lack of segregation of duties necessary for an effective system of internal control. The material weakness identified did not result in the restatement of any previously reported financial statements or any other related financial disclosure, nor does management believe that it had any effect on the accuracy of the Company’sour financial statements for the current reporting period.
 
In order to mitigate this material weakness to the fullest extent possible, all quarterly financial reports are reviewed by the Chief Executive Officer as well as the Audit Committeeaudit committee for reasonableness. All unexpected results are investigated. At any time, if it appears that any control can be implemented to continue to mitigate such weaknesses, such control procedures areit is immediately implemented. We intend to implement appropriate procedures for monitoring and review of work performed by our Chief Financial Officer.
 
Changes in Internal Control over Financial Reporting
 
During the most recently completed fiscal quarter, there has beenThere were no changechanges in our internal control over financial reporting that hasoccurred during our last fiscal quarter that have materially affected, or isare reasonably likely to materially affect, our internal control over financial reporting.

17


PART IIII.
OTHER INFORMATION

Item 6.1.
Exhibits.Legal Proceedings
 
On October 19, 2007, our former President, CEO, and member of the Board of Directors, filed a lawsuit in the Miami-Dade County Circuit Court claiming failure to pay bonuses, severance, and other benefits in connection with his previously reported termination by us. We have filed a motion to Compel Arbitration and Stay Proceedings as provided by the employment contract with us. On April 16, 2008, the court granted our motion and ordered (i) that the Plaintiff commence arbitration in accordance with the terms of the employment agreement within six (6) months of the date of the order and (ii) all proceedings are stayed until the conclusion of the arbitration proceedings.  Pursuant to the court order, if arbitration is not timely commenced the action will be dismissed. We believe the employee's claims are without merit and intends to defend the action vigorously. The settlement of this action is not expected to have a material impact on our financial position.
16


Item 2.
Exhibits.

Exhibit Number Exhibit
   
3(i).4Second Amended and Restated Articles of Incorporation of Celsia Technologies, Inc.
31.1 Certification pursuant to Section 302 ofRules 13a – 14(a) and 15d – 14(a) under the Sarbanes-OxleySecurities Exchange Act of 2002.1934, as amended.
   
31.2 Certification pursuant to Section 302 ofRules 13a – 14(a) and 15d – 14(a) under the Sarbanes-OxleySecurities Exchange Act of 2002.1934, as amended.
   
32.1 Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.1350.
   
32.2 Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.1350.

1817


SIGNATURES

In accordance withPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
CELSIA TECHNOLOGIES, INC.
 (Registrant)
  
Date: MayNovember 13, 2008By: /s/ Joseph C. Formichelli
  Joseph C. Formichelli
  Chief Executive Officer
   
 By:/s/ Jorge A. Fernandez
  Jorge A. Fernandez
  Chief Financial Officer

1918

 
EXHIBIT INDEX
 
The following exhibits are filed as part of this Form 10-Q
 
Exhibit No.
 
Description
   
3(i).4Second Amended and Restated Articles of Incorporation of Celsia Technologies, Inc.
31.1 Certification of Chief Executive Officer Pursuant to Section 302 ofRules 13a – 14(a) and 15d – 14(a) under the Sarbanes-OxleySecurities Exchange Act of 2002.1934, as amended.
   
31.2 Certification of Chief Financial Officer Pursuant to Section 302 ofRules 13a – 14(a) and 15d – 14(a) under the Sarbanes-OxleySecurities Exchange Act of 2002.1934, as amended.
   
32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 906 of the Sarbanes-Oxley Act of 2002.1350.
   
32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 906 of the Sarbanes-Oxley Act of 2002.1350.
 
2019